Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionFinancial Advisory Service, Inc.
Latest Disclosed Ownership310,018 shares
Latest Disclosed Value $ 10,788,627
Financial Advisory Service, Inc. reports 0.55% increase in ownership of HTD / Corcept Therapeutics Incorporated

On February 18, 2026 - Financial Advisory Service, Inc. filed a 13F-HR form disclosing ownership of 310,018 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $20,963,417 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 29, 2025 disclosing 308,318 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 0.55% during the quarter. The current value of the position is $19,605,538 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-18 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 310,018 1,700 0.55 10,789 -57.90 0.6972
2025-10-29 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 308,318 5,889 1.95 25,624 15.43 1.7354
2025-08-14 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 302,429 2,166 0.72 22,198 -35.28 1.6421
2025-05-05 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 300,263 -8,944 -2.89 34,296 120.13 2.7976
2025-02-14 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 309,207 -6,542 -2.07 15,581 6.62 1.3083
2024-10-17 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 315,749 -23 -0.01 14,613 42.43 1.1622
2024-07-29 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 315,772 4,389 1.41 10,259 30.80 0.8866
2024-04-29 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 311,383 1,092 0.35 7,844 -22.18 0.6951
2024-01-23 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 310,291 -473 -0.15 10,078 19.04 0.9575
2023-10-23 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 310,764 -7 -0.00 8,467 22.45 0.9051
2023-08-08 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 310,771 5,745 1.88 6,915 4.66 0.8747
2023-05-11 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 305,026 -1,250 -0.41 6,607 6.21 0.7162
2023-02-01 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 306,276 6,700 2.24 6,220 -19.02 0.7048
2022-10-20 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 299,576 -204 -0.07 7,681 7.74 0.8530
2022-08-02 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 299,780 10,155 3.51 7,129 9.31 0.7504
2022-05-04 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 289,625 4,283 1.50 6,522 15.43 0.6138
2022-02-11 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 285,342 -300 -0.11 5,650 0.52 0.5185
2021-11-15 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 285,642 3,680 1.31 5,621 -9.38 0.5262
2021-07-29 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 281,962 45,921 19.45 6,203 10.47 0.5821
2021-05-17 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 236,041 14,996 6.78 5,615 -2.91 0.5845
2021-02-10 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 221,045 5,415 2.51 5,783 54.09 0.6579
2020-11-16 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 215,630 18,490 9.38 3,753 13.18 0.5127
2020-07-21 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 197,140 -5,357 -2.65 3,316 37.71 0.4886
2020-05-14 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 202,497 202,497 2,408 0.4212
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.